Q4 2024 Holdings
Filed 2025-02-14 | 90 holdings | $7.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scilex Holding Co(SCLXUSD) | SH | 80880W106 | $441.8K | 1,036,218 | 0.0% |
| Regulus Therapeutics Inc(RGLS) | SH | 75915K309 | $532.2K | 336,843 | 0.0% |
| Scholar Rock Holding Corp(SRRK) | SH | 80706P103 | $761.4K | 17,616 | 0.0% |
| Allakos Inc(ALLKGUSD) | SH | 01671P100 | $1.4M | 1,129,931 | 0.0% |
| Lexeo Therapeutics Inc(LXEO) | SH | 52886X107 | $3.6M | 546,554 | 0.0% |
| Surrozen Inc(SRZN) | SH | 86889P208 | $4.1M | 282,580 | 0.1% |
| Newamsterdam Pharma Co NV | SH | N62509117 | $4.7M | 333,333 | 0.1% |
| Enanta Pharmaceuticals Inc(ENTA) | SH | 29251M106 | $6.0M | 1,038,000 | 0.1% |
| Boundless BIO Inc(BOLD) | SH | 10170A100 | $6.3M | 2,180,631 | 0.1% |
| Avalo Therapeutics Inc(AVTX) | SH | 05338F306 | $7.2M | 967,000 | 0.1% |
| Adicet BIO Inc(TORCEUR) | SH | 007002108 | $7.3M | 7,541,000 | 0.1% |
| Bioage Labs Inc(BIOA) | SH | 09077V100 | $7.6M | 1,310,589 | 0.1% |
| Perceptive Capital Solutions | SH | G70077105 | $7.6M | 750,000 | 0.1% |
| Zura BIO LTD(ZURA) | SH | G9TY5A101 | $8.0M | 3,217,503 | 0.1% |
| Arvinas Inc(ARVN) | SH | 04335A105 | $8.1M | 421,348 | 0.1% |
| Werewolf Therapeutics Inc(HOWL) | SH | 95075A107 | $9.1M | 6,144,881 | 0.1% |
| Third Harmonic BIO Inc(THRD) | SH | 88427A107 | $9.9M | 960,620 | 0.1% |
| Monopar Therapeutics Inc(MNPR) | SH | 61023L207 | $11.2M | 511,207 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | SH | 00461U105 | $11.6M | 4,666,667 | 0.2% |
| Immatics NV(IMTX) | SH | N44445109 | $12.4M | 1,750,000 | 0.2% |
| Xencor Inc(XNCR) | SH | 98401F105 | $13.2M | 575,000 | 0.2% |
| Insmed Inc(INSM) | SH | 457669307 | $13.8M | 200,000 | 0.2% |
| Eledon Pharmaceuticals Inc(ELDN) | SH | 28617K101 | $14.7M | 3,566,338 | 0.2% |
| Bicycle Therapeutics PLC(BCYC) | SH | 088786108 | $15.3M | 1,093,477 | 0.2% |
| Iteos Therapeutics Inc(5E7) | SH | 46565G104 | $16.1M | 2,092,259 | 0.2% |
| Bright Minds Biosciences Inc(DRUG) | SH | 10919W405 | $16.6M | 460,829 | 0.2% |
| Pliant Therapeutics Inc(PLRX) | SH | 729139105 | $16.9M | 1,281,000 | 0.2% |
| Solid Biosciences Inc(SLDB) | SH | 83422E204 | $17.3M | 4,330,446 | 0.2% |
| C4 Therapeutics Inc(CCCC) | SH | 12529R107 | $17.6M | 4,878,000 | 0.2% |
| Protara Therapeutic Inc(TARA) | SH | 74365U107 | $18.0M | 3,400,000 | 0.2% |
| Alector Inc(ALEC) | SH | 014442107 | $18.3M | 9,695,228 | 0.2% |
| Taysha Gene Therapies Inc(TSHA) | SH | 877619106 | $18.8M | 10,872,503 | 0.3% |
| Enliven Therapeutics Inc(ELVN) | SH | 29337E102 | $19.1M | 848,986 | 0.3% |
| Travere Therapeutics Inc(TVTX) | SH | 89422G107 | $20.0M | 1,150,000 | 0.3% |
| Ceribell Inc(CBLL) | SH | 15678C102 | $21.3M | 824,582 | 0.3% |
| Larimar Therapeutics Inc(LRMR) | SH | 517125100 | $23.4M | 6,045,351 | 0.3% |
| Eyepoint Pharmaceuticals Inc(EYPT) | SH | 30233G209 | $23.7M | 3,181,818 | 0.3% |
| Aerovate Therapeutics Inc | SH | 008064107 | $24.4M | 9,192,092 | 0.3% |
| Sera Prognostics Inc(SERA) | SH | 81749D107 | $24.7M | 3,032,808 | 0.3% |
| Nurix Therapeutics Inc(NRIX) | SH | 67080M103 | $25.1M | 1,333,333 | 0.3% |
| 4D Molecular Therapeutics in(FDMT) | SH | 35104E100 | $25.4M | 4,563,211 | 0.3% |
| Acumen Pharmaceuticals Inc(ABOS) | SH | 00509G209 | $25.7M | 14,932,063 | 0.3% |
| Nkarta Inc(NKTX) | SH | 65487U108 | $26.9M | 10,805,129 | 0.4% |
| MBX Biosciences Inc(MBX) | SH | 55287L101 | $27.9M | 1,511,334 | 0.4% |
| Cidara Therapeutics Inc(CDTX) | SH | 171757206 | $29.4M | 1,092,796 | 0.4% |
| Chimerix Inc(CMRXEUR) | SH | 16934W106 | $30.6M | 8,800,000 | 0.4% |
| ZAI LAB LTD(ZLAB) | SH | 98887Q104 | $33.9M | 1,295,040 | 0.5% |
| Ideaya Biosciences Inc(IDYA) | SH | 45166A102 | $34.6M | 1,347,252 | 0.5% |
| Kura Oncology Inc(KURA) | SH | 50127T109 | $38.8M | 4,451,041 | 0.5% |
| Evolent Health Inc(EVH) | SH | 30050B101 | $40.2M | 3,577,197 | 0.5% |